Search

everythinglearnresearchcommunity

for

Search:↓

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Skin diseases like psoriasis, lupus, and others can increase heart disease risk due to factors like chronic inflammation and genetic susceptibility.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

Lack of Evi in skin causes psoriasis-like symptoms in mice.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Imbalance in scalp bacteria can affect hair and scalp health, potentially leading to conditions like hair loss, psoriasis, and dandruff.

Some drugs for inflammation may cause psoriasis-like hair loss.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Blocking TSLP reduces skin inflammation and cell overgrowth in psoriasis.

Laminin-511 may contribute to psoriasis by affecting skin cell growth and survival.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

Loss of a specific protein in skin cells causes symptoms similar to psoriasis.

Patients with ichthyosis often experience symptoms similar to psoriasis and atopic dermatitis, suggesting that targeted therapies could improve their condition.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Fisetin may help treat psoriasis and reduce skin inflammation.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

UV radiation may cause DNA changes in skin, certain UVB therapy helps psoriasis, a new gene mutation is linked to mild piebaldism, different immune cells affect psoriasis, a drug promotes hair growth, and some cancer drugs could treat skin barrier issues.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Sensitive skin is often caused by nerve fibers and environmental factors, and can be managed with mild skincare and professional advice.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Fish oil increased cell growth and macrophages in the skin but didn't affect COX-2 expression.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.